HIGHLIGHTS
- who: Takehiko Tsumura and collaborators from the Department of Medical Oncology, Osaka Red Cross Hospital, Osaka, Japan have published the Article: Precision Medicine of Hepatobiliary and Pancreatic Cancers: Focusing on Clinical Trial Outcomes, in the Journal: Cancers 2022, 14, 3674. of 15/06/2022
- what: In this study, the ORR for 27 tumor types, including BTC and PDAC, were reported as 34.3 (80/233, 95% CI: 28.3-40.8%), and those of BTC and PDAC were reported as 40.9 (9/22, 95% CI: 20.7-63.6%) and 18.2% (4/22 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.